Form 4: Zoetis Executive Vice President Robert J. Polzer Executes Stock Options and Sells Shares
SEC Form 4 Filing
Executive Vice President of Zoetis Inc., Robert J. Polzer, exercised stock options and sold shares on November 25, 2024, according to a recent SEC filing.
Summary
- Robert J. Polzer, an Executive Vice President at Zoetis Inc., engaged in multiple transactions involving the company's stock on November 25, 2024.
- He exercised stock options to acquire 1,057 shares at $160.62 per share and 2,420 shares at $162.07 per share.
- Following the exercise of these options, he sold 3,477 shares at a weighted average price of $177.46 per share.
- After these transactions, Mr. Polzer directly owns 3,249 shares and indirectly owns 1,059.8582 shares through a 401(k) plan.
- The transactions also involved stock options granted in previous years, with varying vesting schedules and exercise prices.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing detailing stock transactions by an executive, which is neither positive nor negative in itself. It's a neutral event.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the trading activities of insiders.
Comparison to Industry Standards
- Executive stock transactions are a common occurrence in publicly listed companies like Zoetis, and are typically disclosed via SEC Form 4 filings.
- The vesting schedules and exercise prices of the stock options are typical for executive compensation packages in the pharmaceutical and animal health industries.
- Companies like Elanco and IDEXX also have similar reporting requirements for their executives' stock transactions.
Stakeholder Impact
- The transactions may have a minor impact on the stock price due to the sale of shares by an executive, but this is generally considered a normal market activity.
- The filing provides transparency to shareholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 2021-02-10 | Grant date of 1,057 stock options at an exercise price of $160.62 per option. |
| 2022-02-08 | Grant date of 5,455 stock options at an exercise price of $201.30 per option. |
| 2023-02-08 | Grant date of stock options that vest over three years. |
| 2024-02-06 | Grant date of stock options that vest over three years. |
| 2024-09-30 | Date of common stock equivalents held in the Zoetis Inc. Savings Plan. |
| 2024-11-25 | Date of stock option exercises and share sales by Robert J. Polzer. |
| 2024-11-26 | Date of filing of the SEC Form 4. |
Keywords
Zoetis, Stock Options, SEC Form 4, Executive Stock Transactions, Insider Trading, Robert J. Polzer, ZTS
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.